Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -146,412 | -137,467 | -80,348 | -45,621 | -162,857 |
| Depreciation Amortization | 28,821 | 20,901 | 13,665 | 6,605 | 96,998 |
| Accounts receivable | N/A | -15,957 | N/A | -1,133 | N/A |
| Accounts payable and accrued liabilities | 3,457 | -2,286 | -7,356 | -3,409 | 10,635 |
| Other Working Capital | -70,694 | -24,475 | -6,338 | 10,463 | -25,843 |
| Other Operating Activity | 53,533 | 62,732 | 36,419 | 21,541 | -27,489 |
| Operating Cash Flow | $-131,295 | $-96,552 | $-43,958 | $-11,554 | $-108,556 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 103,296 | 54,946 | 7,460 | 23,154 | 172,796 |
| PPE Investments | -42,772 | -32,929 | -24,001 | -10,636 | -78,396 |
| Net Acquisitions | 30,113 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -24,230 | -16,771 | -13,783 | -5,601 | -8,699 |
| Other Investing Activity | 21,343 | 7,366 | 6,448 | 1,018 | 35,708 |
| Investing Cash Flow | $87,750 | $12,612 | $-23,876 | $7,935 | $121,409 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,731 | N/A | 11,653 | N/A | 13,498 |
| Common Stock Issued | N/A | 19,207 | N/A | 6,148 | N/A |
| Other Financing Activity | -15,649 | -9,240 | -9,058 | -178 | -729 |
| Financing Cash Flow | $14,082 | $9,967 | $2,595 | $5,970 | $12,769 |
| Exchange Rate Effect | 1,097 | 807 | 1,351 | 590 | -2,617 |
| Beginning Cash Position | 183,615 | 183,615 | 183,615 | 183,615 | 160,610 |
| End Cash Position | 155,249 | 110,449 | 119,727 | 186,556 | 183,615 |
| Net Cash Flow | $-28,366 | $-73,166 | $-63,888 | $2,941 | $23,005 |
| Free Cash Flow | |||||
| Operating Cash Flow | -131,295 | -96,552 | -43,958 | -11,554 | -108,556 |
| Capital Expenditure | -42,772 | -32,929 | -24,001 | -10,636 | -78,396 |
| Free Cash Flow | -174,067 | -129,481 | -67,959 | -22,190 | -186,952 |